Obesity with Vitamin D deficiency tied to increased risk of depression

Written By :  Aditi
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-02-17 14:30 GMT   |   Update On 2023-02-17 14:31 GMT
Advertisement

A study published in Clinical Laboratory has concluded that individuals at risk of depression have higher BMI and lower serum Vitamin D levels.

Previous research has associated vitamin D deficiency or hypovitaminosis with obesity and depression. A team of researchers investigated this further on,

“What is the association of vitamin D with depression in obese patients?”

The study included 107 obese patients who were followed up and treated at an obesity centre. There were two groups; one group was deficient in vitamin D with a serum 25(OH)D level of < 20 ng/mL, while the other not deficient group had a serum vitamin D level of ≥ 20 ng/mL.

Advertisement

According to BDI scores, patients were divided into two groups with BDI scores < 17 and ≥ 17.

The study results are summarised as follows:

  • Those with a higher risk for depression with a BDI score ≥ 17 had higher weight and BMI. These patients had lower levels of serum 25(OH)D levels.
  • There was a moderate positive association of BDI scores with BMI, a weakly negative relationship with vitamin D levels, weakly positive relationship with weight.
  • The BDI score me-dians of 12 and 8 were higher in patients with serum 25(OH)D levels of < 20 ng/mL than ≥ 20 ng/mL.
  • There was a higher risk of depression due to increased BMI and decreased serum vitamin D levels.

Researchers said that serum vitamin D is a parameter that reveals those at risk of depression.

There was 92.86 % sensitivity and 68.82 % selectivity regarding the cutoff point of 25(OH)D ≤ 19.21 level (Youden index).

Obese patients at risk of depression have higher BMI and lower vitamin D levels.

Vitamin D supplementation has a therapeutic role in preventing depression.

Further reading:

Nur-Eke, Remziye, and Ibrahim Eke. “The Impact of Vitamin D Deficiency on Depression in Obese Adults.” Clinical Laboratory, vol. 69, no. 02/2023, Clinical Laboratory Publications, 2023. Crossref, https://doi.org/10.7754/clin.lab.2022.220526.


Tags:    
Article Source : Clinical Laboratory Journal

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News